This event has ended. Visit the official site or create your own event on Sched.
Learn the latest cancer care information to benefit your patients and earn up to 30 CNE contact hours! Register now at congress.ons.org.
Back To Schedule
Thursday, April 28 • 6:00am - 7:30am
Latest Developments in Treating MDS: An Update on Molecular Testing, Low-Risk and High-Risk MDS Therapies, and Disease Management

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

This breakfast symposium will focus on the role of molecular testing in diagnosing myelodysplastic syndromes (MDS) and targeting treatment; the latest therapy options for low-risk and high-risk MDS patients; and disease management strategies to address quality of life issues and treatment adherence.  Case studies will be used to illustrate the clinical value of molecular testing for MDS, best supportive care options, and care planning. 

This symposium is supported by an independent medical education grant from Celgene Corporation 

Please click here to register for this event.

Thursday April 28, 2016 6:00am - 7:30am CDT
Grand Hyatt, Lonestar Ballroom ABC